Last reviewed · How we verify

NCT07184203

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

Recruiting now NA Last updated 19 September 2025
What this trial tests

NA trial testing Itraconazole (ITZ) in Tinea Capitis in 120 participants. Currently enrolling.

Timeline
9 March 2025
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment120
Start date9 March 2025
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 5 to 18, any sex, with Tinea Capitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Itraconazole (ITZ)

Trials testing the same drug.

Other recruiting trials for Tinea Capitis

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07184203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing